SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001640334-23-001869
Filing Date
2023-10-18
Accepted
2023-10-18 12:25:11
Documents
14
Period of Report
2023-10-17
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 FORM 8-K lxrp_8k.htm   iXBRL 8-K 25904
  Complete submission text file 0001640334-23-001869.txt   149483

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA lxrp-20231017.xsd EX-101.SCH 5720
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE lxrp-20231017_lab.xml EX-101.LAB 14635
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE lxrp-20231017_cal.xml EX-101.CAL 898
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lxrp-20231017_pre.xml EX-101.PRE 9260
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lxrp-20231017_def.xml EX-101.DEF 2099
8 EXTRACTED XBRL INSTANCE DOCUMENT lxrp_8k_htm.xml XML 3599
Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Filer) CIK: 0001348362 (see all company filings)

IRS No.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 8-K | Act: 34 | File No.: 001-39874 | Film No.: 231331553
SIC: 2834 Pharmaceutical Preparations